Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial

被引：0
|
作者：
Maurice B. Bizino
Ingrid M. Jazet
Jos J. M. Westenberg
Huub J. van Eyk
Elisabeth H. M. Paiman
Jan W. A. Smit
Hildebrandus J. Lamb
机构：
[1] Leiden University Medical Center,Department of Radiology
[2] Leiden University Medical Center,Department of Medicine, Division of Endocrinology
[3] Radboud University Medical Center,Department of Medicine
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Diabetes mellitus type 2; Liraglutide; GLP1-receptor agonist; Diastolic heart failure; Cardiac function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
    Bizino, Maurice B.
    Jazet, Ingrid M.
    Westenberg, Jos J. M.
    van Eyk, Huub J.
    Paiman, Elisabeth H. M.
    Smit, Jan W. A.
    Lamb, Hildebrandus J.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18
  • [2] Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
    Maurice B. Bizino
    Ingrid M. Jazet
    Jos J. M. Westenberg
    Huub J. van Eyk
    Elisabeth H. M. Paiman
    Jan W. A. Smit
    Hildebrandus J. Lamb
    Cardiovascular Diabetology, 18
  • [3] Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial (vol 18, pg 55, 2019)
    Bizino, Maurice B.
    Jazet, Ingrid M.
    Westenberg, Jos J. M.
    van Eyk, Huub J.
    Paiman, Elisabeth H. M.
    Smit, Jan W. A.
    Lamb, Hildebrandus J.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [4] Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
    Xia, Wenjing
    Yu, Hua
    Lei, Xia
    Wen, Pengcheng
    MEDICINE, 2024, 103 (11) : E37432
  • [5] Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trial
    Rasmussen, Ida K. B.
    Zobel, Emilie H.
    Ripa, Rasmus S.
    von Scholten, Bernt J.
    Curovic, Viktor R.
    Jensen, Jacob K.
    Kjaer, Andreas
    Hansen, Tine W.
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2651 - 2659
  • [6] Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials
    Qiang Du
    Yan-Jun Wang
    Sheng Yang
    Yue-Yang Zhao
    Ping Han
    Advances in Therapy, 2014, 31 : 1182 - 1195
  • [7] Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials
    Du, Qiang
    Wang, Yan-Jun
    Yang, Sheng
    Zhao, Yue-Yang
    Han, Ping
    ADVANCES IN THERAPY, 2014, 31 (11) : 1182 - 1195
  • [8] The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial
    Sivalingam, Suvanjaa
    Hein Zobel, Emilie
    Hansen, Christian S.
    Ripa, Rasmus S.
    von Scholten, Bernt J.
    Rotbain Curovic, Viktor
    Kjaer, Andreas
    Jensen, Jacob K.
    Hansen, Tine W.
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2022, 24 (08): : 1638 - 1642
  • [9] Effect of Bergenia ligulata (Wall.) in type 2 diabetes mellitus: A randomized placebo-controlled trial
    Nizamudeen, S.
    Bhat, Muzafar Din Ahmad
    Malik, Rabia
    Fatima, Mehjabeen
    Radhika, K.
    Najar, Firdous Ahmad
    Shah, Altaf Hussain
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2024, 67
  • [10] Dapagliflozin for Remission of Type 2 Diabetes Mellitus: A Multicenter Randomized Placebo-controlled Trial
    Liu, Y.
    Ma, J.
    Shi, L.
    Kuang, H.
    Xue, Y.
    Li, X.
    Xu, Y.
    Feng, B.
    Wang, G.
    Zhu, D.
    Zhang, H.
    Li, X.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
12345